Comparative Analysis of the Most Important Cardiovascular Risk Factors Based on Cross-Sectional Studies in the Population of Latvia.


Journal

Medicina (Kaunas, Lithuania)
ISSN: 1648-9144
Titre abrégé: Medicina (Kaunas)
Pays: Switzerland
ID NLM: 9425208

Informations de publication

Date de publication:
06 May 2022
Historique:
received: 04 04 2022
revised: 28 04 2022
accepted: 29 04 2022
entrez: 28 5 2022
pubmed: 29 5 2022
medline: 1 6 2022
Statut: epublish

Résumé

Background and Objectives: The aim of the study was to analyze the prevalence of cardiovascular risk factors (RFs) in Latvia from the population-based cross-sectional study performed in 2019−2020 and to compare the results with a similar study done in 2009−2010. Materials and Methods: The target sample of 6000 individuals representing a cross-section of Latvia’s inhabitants (aged 25−74) was formed using stratified two-stage cluster sampling. The survey had two components: (1) an interview using a pre-specified questionnaire and (2) physical examination (height, weight, arterial pressure) and collection of venous blood samples to measure levels of fasting glucose (Glu), total cholesterol (TC), high and low-density lipoprotein cholesterol (HDL-C/LDL-C), and triglycerides (Tg). In total, 4070 individuals were interviewed (32% non-response), from which 2218 (55%) individuals underwent physical examination and collection of blood samples. Results: The most frequently observed RFs were high LDL-C (62.0%), smoking (45.3%), and arterial hypertension (36.8%), while the prevalence of self-reported high cholesterol and hypertension was 19.3 and 18.6%, respectively. A decrease in the prevalence of hypertension, high LDL-C, and Glu was noted. Smoking decreased in younger men. The mean number of five most important cardiovascular RFs was 2.0 (95% confidence interval (CI) 2.0, 2.1); 2.3 (95% CI 2.2, 2.4) for men and 1.8 (95% CI 1.7, 19) for women. The average number of RFs has decreased by 0.3 in 10 years, t(5883) = −7.2, p < 0.001. Conclusions: Although the prevalence of cardiovascular RFs remains noteworthy, an improvement in the risk profile of the Latvian population has been observed over the past decade. The study shows subjective self-underestimation of cardiovascular risk.

Identifiants

pubmed: 35630060
pii: medicina58050643
doi: 10.3390/medicina58050643
pmc: PMC9143214
pii:
doi:

Substances chimiques

Cholesterol, HDL 0
Cholesterol, LDL 0
Cholesterol 97C5T2UQ7J

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : the European Social Fund within the project Complex Health Promotion and Disease Prevention Measures
ID : 9.2.4.1/16/I/001

Références

Eur Heart J. 2016 Aug 1;37(29):2315-2381
pubmed: 27222591
Eur Heart J. 2020 Jan 7;41(2):255-323
pubmed: 31497854
Lancet. 2015 Dec 5;386(10010):2287-323
pubmed: 26364544
Medicina (Kaunas). 2012;48(6):310-6
pubmed: 22885365
Vasc Health Risk Manag. 2007;3(4):389-400
pubmed: 17969368
Eur Heart J. 2020 Jan 1;41(1):111-188
pubmed: 31504418
Eur J Prev Cardiol. 2016 Apr;23(6):636-48
pubmed: 25687109
Lancet. 2019 Aug 24;394(10199):639-651
pubmed: 31327564

Auteurs

Andrejs Erglis (A)

Institute of Cardiology and Regenerative Medicine, University of Latvia, LV-1004 Riga, Latvia.
Latvian Centre of Cardiology, Pauls Stradins Clinical University Hospital, LV-1002 Riga, Latvia.

Iveta Bajare (I)

Institute of Cardiology and Regenerative Medicine, University of Latvia, LV-1004 Riga, Latvia.

Sanda Jegere (S)

Institute of Cardiology and Regenerative Medicine, University of Latvia, LV-1004 Riga, Latvia.
Latvian Centre of Cardiology, Pauls Stradins Clinical University Hospital, LV-1002 Riga, Latvia.

Iveta Mintale (I)

Institute of Cardiology and Regenerative Medicine, University of Latvia, LV-1004 Riga, Latvia.
Latvian Centre of Cardiology, Pauls Stradins Clinical University Hospital, LV-1002 Riga, Latvia.

Juris Barzdins (J)

Faculty of Physics, Mathematics and Optometry, University of Latvia, LV-1004 Riga, Latvia.

Artis Luguzis (A)

Faculty of Physics, Mathematics and Optometry, University of Latvia, LV-1004 Riga, Latvia.

Peteris Apinis (P)

Institute of Cardiology and Regenerative Medicine, University of Latvia, LV-1004 Riga, Latvia.
Latvian Medical Association, LV-1010 Riga, Latvia.

Anda Caksa (A)

Institute of Cardiology and Regenerative Medicine, University of Latvia, LV-1004 Riga, Latvia.

Iveta Gavare (I)

Centre for Disease Prevention and Control, LV-1005 Riga, Latvia.

Vilnis Dzerve (V)

Institute of Cardiology and Regenerative Medicine, University of Latvia, LV-1004 Riga, Latvia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH